annual shareholders equity:
$5.66B+$706.44M(+14.27%)Summary
- As of today (September 13, 2025), BMRN annual stockholders equity is $5.66 billion, with the most recent change of +$706.44 million (+14.27%) on December 31, 2024.
- During the last 3 years, BMRN annual shareholders equity has risen by +$1.39 billion (+32.48%).
- BMRN annual shareholders equity is now at all-time high.
Performance
BMRN Shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly shareholders equity:
$6.03B+$233.65M(+4.03%)Summary
- As of today (September 13, 2025), BMRN quarterly stockholders equity is $6.03 billion, with the most recent change of +$233.65 million (+4.03%) on June 30, 2025.
- Over the past year, BMRN quarterly shareholders equity has increased by +$740.81 million (+14.01%).
- BMRN quarterly shareholders equity is now at all-time high.
Performance
BMRN quarterly shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Shareholders equity Formula
Shareholders Equity = Total Assets − Total Liabilities
BMRN Shareholders equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +14.3% | +14.0% |
| 3 y3 years | +32.5% | +33.8% |
| 5 y5 years | +81.2% | +86.2% |
BMRN Shareholders equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +32.5% | at high | +33.8% |
| 5 y | 5-year | at high | +81.2% | at high | +86.2% |
| alltime | all time | at high | +7404.2% | at high | +5557.3% |
BMRN Shareholders equity History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $6.03B(+4.0%) |
| Mar 2025 | - | $5.79B(+2.4%) |
| Dec 2024 | $5.66B(+14.3%) | $5.66B(+4.5%) |
| Sep 2024 | - | $5.41B(+2.4%) |
| Jun 2024 | - | $5.29B(+4.2%) |
| Mar 2024 | - | $5.07B(+2.5%) |
| Dec 2023 | $4.95B(+7.6%) | $4.95B(+1.1%) |
| Sep 2023 | - | $4.90B(+2.4%) |
| Jun 2023 | - | $4.78B(+2.7%) |
| Mar 2023 | - | $4.66B(+1.2%) |
| Dec 2022 | $4.60B(+7.8%) | $4.60B(+0.8%) |
| Sep 2022 | - | $4.57B(+1.4%) |
| Jun 2022 | - | $4.50B(+2.6%) |
| Mar 2022 | - | $4.39B(+2.8%) |
| Dec 2021 | $4.27B(+4.0%) | $4.27B(+0.1%) |
| Sep 2021 | - | $4.27B(+0.6%) |
| Jun 2021 | - | $4.24B(+1.9%) |
| Mar 2021 | - | $4.16B(+1.4%) |
| Dec 2020 | $4.11B(+31.5%) | $4.11B(+1.3%) |
| Sep 2020 | - | $4.05B(+25.2%) |
| Jun 2020 | - | $3.24B(-0.1%) |
| Mar 2020 | - | $3.24B(+3.8%) |
| Dec 2019 | $3.12B(+5.2%) | $3.12B(+1.6%) |
| Sep 2019 | - | $3.07B(+3.8%) |
| Jun 2019 | - | $2.96B(+0.8%) |
| Mar 2019 | - | $2.94B(-1.1%) |
| Dec 2018 | $2.97B(+5.7%) | $2.97B(+1.8%) |
| Sep 2018 | - | $2.91B(+1.0%) |
| Jun 2018 | - | $2.89B(+2.8%) |
| Mar 2018 | - | $2.81B(-0.1%) |
| Dec 2017 | $2.81B(+1.5%) | $2.81B(-0.2%) |
| Sep 2017 | - | $2.81B(+0.6%) |
| Jun 2017 | - | $2.80B(+1.0%) |
| Mar 2017 | - | $2.77B(+0.1%) |
| Dec 2016 | $2.77B(+15.2%) | $2.77B(+4.6%) |
| Sep 2016 | - | $2.65B(+38.0%) |
| Jun 2016 | - | $1.92B(-16.3%) |
| Mar 2016 | - | $2.29B(-4.6%) |
| Dec 2015 | $2.40B(+57.1%) | $2.40B(+4.7%) |
| Sep 2015 | - | $2.29B(-2.7%) |
| Jun 2015 | - | $2.36B(-2.8%) |
| Mar 2015 | - | $2.43B(+58.7%) |
| Dec 2014 | $1.53B(+13.9%) | $1.53B(+1.3%) |
| Sep 2014 | - | $1.51B(+3.2%) |
| Jun 2014 | - | $1.46B(+0.1%) |
| Mar 2014 | - | $1.46B(+8.9%) |
| Dec 2013 | $1.34B(+32.0%) | $1.34B(+5.1%) |
| Sep 2013 | - | $1.28B(+1.4%) |
| Jun 2013 | - | $1.26B(+0.6%) |
| Mar 2013 | - | $1.25B(+23.1%) |
| Dec 2012 | $1.02B(+31.4%) | $1.02B(+0.1%) |
| Sep 2012 | - | $1.02B(+1.5%) |
| Jun 2012 | - | $1.00B(+29.6%) |
| Mar 2012 | - | $771.95M(-0.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $773.05M(+7.8%) | $773.05M(-0.2%) |
| Sep 2011 | - | $774.54M(+5.8%) |
| Jun 2011 | - | $732.30M(+1.6%) |
| Mar 2011 | - | $720.84M(+0.5%) |
| Dec 2010 | $717.26M(+122.6%) | $717.26M(+22.5%) |
| Sep 2010 | - | $585.66M(+61.4%) |
| Jun 2010 | - | $362.96M(+5.1%) |
| Mar 2010 | - | $345.24M(+7.2%) |
| Dec 2009 | $322.19M(+16.4%) | $322.19M(+6.0%) |
| Sep 2009 | - | $303.85M(+7.2%) |
| Jun 2009 | - | $283.43M(+3.5%) |
| Mar 2009 | - | $273.94M(-1.0%) |
| Dec 2008 | $276.68M(+47.4%) | $276.68M(+16.3%) |
| Sep 2008 | - | $237.90M(+5.3%) |
| Jun 2008 | - | $226.03M(+8.1%) |
| Mar 2008 | - | $209.17M(+11.4%) |
| Dec 2007 | $187.73M(+59.4%) | $187.73M(+7.6%) |
| Sep 2007 | - | $174.54M(+4.1%) |
| Jun 2007 | - | $167.60M(+1.8%) |
| Mar 2007 | - | $164.71M(+39.8%) |
| Dec 2006 | $117.80M(-252.1%) | $117.80M(-3.5%) |
| Sep 2006 | - | $122.12M(+149.8%) |
| Jun 2006 | - | $48.89M(+6.3%) |
| Mar 2006 | - | $46.01M(-159.4%) |
| Dec 2005 | -$77.46M(+14.0%) | -$77.46M(+18.5%) |
| Sep 2005 | - | -$65.38M(-40.8%) |
| Jun 2005 | - | -$110.44M(+22.4%) |
| Mar 2005 | - | -$90.23M(+32.7%) |
| Dec 2004 | -$67.98M(-157.7%) | -$67.98M(-580.0%) |
| Sep 2004 | - | $14.16M(-67.2%) |
| Jun 2004 | - | $43.19M(-56.3%) |
| Mar 2004 | - | $98.77M(-16.2%) |
| Dec 2003 | $117.85M(+19.0%) | $117.85M(-17.0%) |
| Sep 2003 | - | $141.96M(-12.8%) |
| Jun 2003 | - | $162.77M(-2.2%) |
| Mar 2003 | - | $166.38M(+68.0%) |
| Dec 2002 | $99.01M(-38.7%) | $99.01M(-15.6%) |
| Sep 2002 | - | $117.27M(-11.8%) |
| Jun 2002 | - | $132.89M(-9.3%) |
| Mar 2002 | - | $146.46M(-9.4%) |
| Dec 2001 | $161.59M(+124.6%) | $161.59M(+87.5%) |
| Sep 2001 | - | $86.18M(-9.3%) |
| Jun 2001 | - | $94.99M(+49.1%) |
| Mar 2001 | - | $63.72M(-11.4%) |
| Dec 2000 | $71.93M(-28.8%) | $71.93M(-11.7%) |
| Sep 2000 | - | $81.47M(-5.2%) |
| Jun 2000 | - | $85.90M(-7.0%) |
| Mar 2000 | - | $92.37M(-8.6%) |
| Dec 1999 | $101.02M(+216.8%) | $101.02M(+216.8%) |
| Sep 1999 | - | $31.88M(+59.3%) |
| Jun 1999 | - | $20.01M(-27.4%) |
| Mar 1999 | - | $27.57M(-13.5%) |
| Dec 1998 | $31.88M(+228.1%) | - |
| Dec 1998 | - | $31.88M |
| Dec 1997 | $9.72M | - |
FAQ
- What is BioMarin Pharmaceutical Inc. annual stockholders equity?
- What is the all time high annual shareholders equity for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. annual shareholders equity year-on-year change?
- What is BioMarin Pharmaceutical Inc. quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. quarterly shareholders equity year-on-year change?
What is BioMarin Pharmaceutical Inc. annual stockholders equity?
The current annual shareholders equity of BMRN is $5.66B
What is the all time high annual shareholders equity for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high annual stockholders equity is $5.66B
What is BioMarin Pharmaceutical Inc. annual shareholders equity year-on-year change?
Over the past year, BMRN annual stockholders equity has changed by +$706.44M (+14.27%)
What is BioMarin Pharmaceutical Inc. quarterly stockholders equity?
The current quarterly shareholders equity of BMRN is $6.03B
What is the all time high quarterly shareholders equity for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high quarterly stockholders equity is $6.03B
What is BioMarin Pharmaceutical Inc. quarterly shareholders equity year-on-year change?
Over the past year, BMRN quarterly stockholders equity has changed by +$740.81M (+14.01%)